Completed NA INTERVENTIONAL 2-arm NCT05647226

Digital Diabetes Remission Trial (DIGEST)

Exploring the Use of Digital Therapeutics Alongside a Remote Intensive Lifestyle Programme on Inducing Weight Loss and Diabetes Remission in Patients With Type 2 Diabetes Versus Standard of Care (DIGEST)

Sponsor: Habitual Health Ltd

Conditions Diabetes Mellitus, Type 2

Interventions Digital therapeutic and intensive lifestyle programme Standard of care

Updated 5 times since 2023 Last updated: Sep 11, 2025 Started: Jan 9, 2022 Primary completion: Jul 30, 2024 Completion: Jul 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05647226, this NA trial focuses on Diabetes Mellitus, Type 2 and remains completed. Sponsored by Habitual Health Ltd, it has been updated 5 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Oct 2025 — Present [monthly]

Completed NA

Status: Unknown → Completed
Jan 2025 — Oct 2025 [monthly]

Unknown NA

Status: Enrolling By Invitation → Unknown
Sep 2024 — Jan 2025 [monthly]

Enrolling By Invitation NA
Jul 2024 — Sep 2024 [monthly]

Enrolling By Invitation NA
Jan 2023 — Jul 2024 [monthly]

Enrolling By Invitation NA

First recorded

Jan 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Habitual Health Ltd
Lindus Health

Data source: Habitual Health Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom